Lataa...
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
The administration of mesenchymal stem cells (MSCs) as a therapy for liver disease holds great promise. MSCs can differentiate into hepatocytes, reduce liver inflammation, promote hepatic regeneration and secrete protective cytokines. However, the risks of iatrogenic tumor formation, cellular reject...
Tallennettuna:
| Julkaisussa: | Exp Mol Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5519012/ https://ncbi.nlm.nih.gov/pubmed/28620221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.63 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|